Brief: Vicore Pharma Q2 EBIT SEK -63.1 Million
22/08/2024 07:00
Aug 22 (Reuters) - Vicore Pharma Q2 sales SEK 0. * Q2 net income SEK -56.3 million * Q2 adjusted EPS SEK -0.5 * Q2 adjusted free cash flow SEK -49.6 million * Q2 cash & investments SEK 466.4 million
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2